Jun Du
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 18
- Cell death mechanisms and regulation 11
- Mechanisms of cancer metastasis 9
- Histone Deacetylase Inhibitors Research 7
- Wnt/β-catenin signaling in development and cancer 7
- Oncology 21
- Co-authors
- Luo Gu (27 shared papers)Yujie Zhang (31 shared papers)Yichao Zhu (12 shared papers)Zhenzhen Hu (7 shared papers)Izumi Nakashima (14 shared papers)Yueyuan Wang (19 shared papers)Jiaojing Liu (7 shared papers)Haruhiko Suzuki (11 shared papers)
- Journals
- PLoS ONE (6 papers)Frontiers in Pharmacology (6 papers)BMC Cancer (5 papers)Journal of Cellular Biochemistry (5 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jun Du
140 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 468
- Oncology 540
- Molecular Biology 1.4k
- Cell Biology 225
- Clinical Biochemistry 65
Countries citing papers authored by Jun Du
This map shows the geographic impact of Jun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Du more than expected).
Fields of papers citing papers by Jun Du
This network shows the impact of papers produced by Jun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Du. The network helps show where Jun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 117 | |
| 2 | 2000 | 114 | |
| 3 | 2012 | 104 | |
| 4 | 2011 | 95 | |
| 5 | 2010 | 88 | |
| 6 | 2012 | 84 | |
| 7 | 2016 | 79 | |
| 8 | 2012 | 78 | |
| 9 | 2016 | 69 | |
| 10 | 2018 | 69 | |
| 11 | 2021 | 69 | |
| 12 | 2004 | 67 | |
| 13 | 2007 | 66 | |
| 14 | 2018 | 66 | |
| 15 | 2013 | 59 | |
| 16 | 2016 | 59 | |
| 17 | 2010 | 55 | |
| 18 | 2016 | 54 | |
| 19 | 2013 | 51 | |
| 20 | Metformin attenuates PD-L1 expression through activating Hippo signaling pathway in colorectal cancer cells. | 2019 | 48 |
About Jun Du
Jun Du is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 146 papers that have together received 3.6k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (18 papers), Gastric Cancer Management and Outcomes (12 papers), Cell death mechanisms and regulation (11 papers), Mechanisms of cancer metastasis (9 papers), Cellular transport and secretion (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Cancer Research (468 citations), Oncology (540 citations), Molecular Biology (1.4k citations), Cell Biology (225 citations) and Clinical Biochemistry (65 citations). Jun Du has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Luo Gu, Yujie Zhang, Yichao Zhu, Zhenzhen Hu, Izumi Nakashima, Yueyuan Wang, Jiaojing Liu, Haruhiko Suzuki, Rui Xu and Hong-Sheng Wang. Their work appears in journals such as PLoS ONE, Frontiers in Pharmacology, BMC Cancer, Journal of Cellular Biochemistry and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.